U.S. drugmaker Pfizer Inc is hoping to rapidly roll out its experimental COVID-19 vaccine around Latin America soon after it gets emergency authorization in the United States, a senior executive said, ...

Pfizer only offered to discount six products through the Most Favored Nation program, and healthcare policy experts suggest ...

Pfizer Inc's experimental COVID-19 vaccine is more than 90% effective based on initial trial results, the drugmaker said on Monday, a major victory in the war against a virus that has killed over a ...

In this week’s edition of InnovationRx, we look at the Haitian immigrant who built a $6 billion company treating brain ...

Newly launched Pfizer drugs will be priced at parity to prices in comparable developed nations, according to the most-favored ...

GoodRx, an online platform that offers drug discount coupons to patients, is in talks with the government to participate in ...

First deals impact Medicaid but drug makers hint they may sell all of their new drugs at most-favored-nation pricing.

Paul LePage wants to remove any doubt that he is fully committed to running for Congress in 2026 in the northern, ...

Calling it a historic step in drug pricing policy, Trump said Pfizer will sell virtually all of its medications at MFN prices ...

AstraZeneca has now joined Pfizer in agreeing to sell its drugs to state Medicaid programs at “most-favored-nation” pricing ...

GoodRx Holdings (NASDAQ:GDRX) stock surged 18% Wednesday after CEO Wendy Barnes suggested the digital healthcare platform could potentially partner with the Trump administration on its new drug ...

Arvinas saw a steep stock price drop after Pfizer decided to stop developing a breast cancer drug with the New Haven–based firm. CEO John Houston told the News about the company’s plans for the future ...